The efficacy of rotigotine [UCB] versus pramipexole in patients with idiopathic Restless Legs Syndrome (Willis-Ekbom Disease).
Phase of Trial: Phase II
Latest Information Update: 22 May 2014
Price : $35 *
At a glance
- Drugs Rotigotine (Primary) ; Pramipexole
- Indications Restless legs syndrome
- Focus Therapeutic Use
- 22 May 2014 New trial record
- 03 May 2014 Results presented at the 66th Annual Meeting of the American Academy of Neurology.